<DOC>
	<DOCNO>NCT01677117</DOCNO>
	<brief_summary>Acute respiratory distress syndrome ( acute respiratory distress syndrome , ARDS ) fatality rate high 20 % -41 % , progress severe ARDS , mortality rise 90 % , main cause death refractory hypoxemia . Mechanical ventilation main measure improve hypoxemia correct hypoxemia relate complication mechanical ventilation , mechanical ventilation treatment severe ARDS gradually challenge . Extracorporeal membrane oxygenation（ECMO ) technology matures , clinician choice face hypoxemia , deepen understanding ECMO , ECMO may become severe ARDS first-line treatment . Currently , ECMO therapy recognize majority medical worker . Therefore , assume accurately grasp ECMO indication standardize implementation treatment significantly improve prognosis , short hospital stay , low hospitalization cost .</brief_summary>
	<brief_title>Clinical Studies Effects Extracorporeal Membrane Oxygenation Severe ARDS Mortality</brief_title>
	<detailed_description />
	<criteria>( 1 ) age 1870 year ; ( 2 ) severe respiratory dysfunction ( Murry score ≥ 3 point clinical optimized ventilation condition pH remain &lt; 7.2 patient ) ; ( 3 ) PaCO2/FiO2 &lt; 100mmHg ; ( 4 ) plateau pressure &gt; 30cmH2O 6h，duration seven day ; ( 5 ) severe respiratory dysfunction etiology reversible . ( 1 ) high level pressure mechanical ventilation ( PEEP &gt; 1520cmH2O / Pplat &gt; 3540cmH2O ) 7 day ; ( 2 ) continue receive high concentration oxygen ( FiO2 &gt; 80 % ) 7 day ; ( 3 ) severe active bleeding ; ( 4 ) within 24 hour surgery head injury intracranial bleeding ; ( 5 ) variety serious irreversible state ; ( 6 ) malignancy ; ( 7 ) progressive pulmonary fibrosis ; ( 8 ) surgical problem ; ( 9 ) due cardiac dysfunction lead ARDS .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>